Connect with us

Press Releases

Alcon Names New Chief Medical Officer




He’ll start on June 1.

(Press Release) FORT WORTH, TX – Alcon, a division of Novartis, has appointed Dr. Stephen S. Lane as chief medical officer and global head franchise clinical strategy. He will join the company on June 1.

In his new role, Lane will lead the integration of scientific, clinical and commercial priorities across Alcon’s Surgical and Vision Care franchises, with a focus on the needs of patients and eyecare practitioners. Lane will also support the generation of Surgical and Vision Care clinical evidence and represent Alcon to academic, scientific and industry communities, and government agencies.

“All of us at Alcon are pleased to welcome Steve to the team,” said Franck Leveiller, senior vice president, global head R&D, Alcon. “His extensive experience in ophthalmic surgery, contact lens and intraocular lens development, clinical trial design and execution, and the regulatory environment complements Alcon’s medical device innovation and commercial execution strategy. Dr. Lane’s knowledge will be invaluable as we continue to develop products that protect and preserve sight, and help eye care practitioners deliver the best visual outcomes for their patients.”

For the past 32 years, Lane has been a world-renowned ophthalmologist specializing in cataract surgery, cornea/external diseases, anterior segment surgery, LASIK and refractive surgery. He is a founding partner of Associated Eye Care, past president of the American Society of Cataract Surgeons, serves on the editorial boards for several ophthalmic journals, is a distinguished lecturer and has published numerous academic articles and book chapters. In addition, he is an adjunct professor of ophthalmology at the University of Minnesota, co-chair of the ASCRS Foundation and a visiting faculty member of ORBIS International, an Alcon partner.


Throughout his career, Lane has been honored with numerous awards, including The American Academy of Ophthalmology Honor Award, Senior Achievement Award and Secretariat Award. He has been named a Top Doctor, including recognition in the top 1 percent of ophthalmologists, by U.S. News, and one of the “34 Best Ophthalmologists in America” by Becker’s ASC Review.

Lane earned his medical degree from the University of Minnesota, completed his ophthalmology residency at Pennsylvania State University and is fellowship-trained in cornea/external disease.



The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular